Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Fulminant demyelinating encephalomyelitis: Insights from antibody studies and neuropathology.
Transient widespread cortical and splenial lesions in acute encephalitis/encephalopathy associated with primary Epstein-Barr virus infection.
Isolation of highly enriched primary human microglia for functional studies.
Social support and depressive symptoms among caregivers of veterans with multiple sclerosis.
Multiple sclerosis and the role of immune cells.
Impact of mast cells on multiple sclerosis: inhibitory effect of natalizumab.
Partial suppression of M1 microglia by Janus kinase 2 inhibitor does not protect against neurodegeneration in animal models of amyotrophic lateral sclerosis.
Antibody Recognition In Multiple Sclerosis And Rett Syndrome Using A Collection Of Linear And Cyclic N-glucosylated antigenic probes.
Application of three focused cluster detection methods to study geographic variation in the incidence of multiple sclerosis in manitoba, Canada.
Longitudinal assessment of clinically isolated syndrome with diffusion tensor imaging and volumetric MRI.
Pregnancy outcomes following maternal and paternal exposure to teriflunomide during treatment for relapsing-remitting multiple sclerosis.
Relation between Pro-inflammatory Cytokines and Acetylcholine Levels in Relapsing-Remitting Multiple Sclerosis Patients.
Modifications of longitudinally extensive transverse myelitis and brainstem lesions in the course of neuromyelitis optica (NMO): a population-based, descriptive study.
Possible new modifications for the McDonald 2010 criteria for the diagnosis of primary progressive multiple sclerosis.
Plaque-like demyelination in acute disseminated encephalomyelitis (ADEM) - an autopsy case report.
Oral BG-12 (dimethyl fumarate) for relapsing-remitting multiple sclerosis: a review of DEFINE and CONFIRM Evaluation of: Gold R, Kappos L, Arnold D, et al. Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis. N Engl J Med 2012;
Efficacy of modafinil on fatigue and excessive daytime sleepiness associated with neurological disorders: a systematic review and meta-analysis.
Acute transverse myelitis during treatment with etanercept for severe plaque psoriasis.
Evolution of the CNS myelin gene regulatory program.
Computational Modelling Approaches on Epigenetic Factors in Neurodegenerative and Autoimmune Diseases and Their Mechanistic Analysis.
The relationship of age with the clinical phenotype in multiple sclerosis.
FDG PET/CT in Acute Tumefactive Multiple Sclerosis Occurring in a Case of Chronic Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation.
Postmortem validation of MRI cortical volume measurements in MS.
Time to target brain atrophy and neurodegeneration in multiple sclerosis.
Interleukin-8 is associated with acute and persistent dysfunction after optic neuritis.
Pages
« first
‹ previous
…
613
614
615
616
617
618
619
620
621
…
next ›
last »